COVID-19 herd immunity v. learning to live with the virus

Area of Science:

• Virology
• Immunology
• Epidemiology

Background:

• SARS-CoV-2 mutations can increase transmissibility and reduce antibody effectiveness.
• COVID-19 vaccines show high efficacy against severe disease, hospitalization, and death, including variants of concern.
• Vaccine effectiveness in preventing infection and transmission is more variable.

Purpose of the Study:

• To analyze the impact of SARS-CoV-2 mutations on vaccine effectiveness.
• To assess the duration of protection offered by COVID-19 vaccines.
• To evaluate the role of vaccination in managing COVID-19 resurgence and achieving normalcy.

Main Methods:

• Review of existing literature on SARS-CoV-2 mutations and vaccine effectiveness.
• Analysis of epidemiological data from countries with high vaccination coverage (UK, Israel).
• Modeling of vaccine-induced protection duration against infection and severe disease.

Main Results:

• COVID-19 vaccines maintain high effectiveness against severe COVID-19, hospitalization, and death despite viral mutations.
• Protection against infection and mild disease is less robust and shorter-lasting.
• High vaccination coverage significantly reduces severe outcomes during variant-driven resurgences.

Conclusions:

• COVID-19 vaccines are crucial for preventing severe disease and death, facilitating a return to normalcy.
• Herd immunity is unlikely, but widespread vaccination protects populations from the worst outcomes.
• Continued monitoring of SARS-CoV-2 evolution and vaccine effectiveness is essential.